Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 51.97% is 19% above its 5-year average of 43.85%, near the high end of its 5-year range (30.76%–53.40%).
0.50% below its 12-month average of 52.23%.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): 52.76%.
GROSS MARGIN
51.97%
GROSS MARGIN AVG TTM
52.23%
GROSS MARGIN AVG 3Y
46.15%
GROSS MARGIN AVG 5Y
43.85%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.50%
CURRENT VS 3Y AVG
+12.61%
CURRENT VS 5Y AVG
+18.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+25.59%
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.55B
Gross Margin
51.97%
TTM Avg
52.23%
3Y Avg
46.15%
5Y Avg
43.85%
Market Cap
$10.75B
Gross Margin
90.69%
TTM Avg
90.21%
3Y Avg
89.67%
5Y Avg
89.38%
Market Cap
$10.32B
Gross Margin
68.55%
TTM Avg
63.16%
3Y Avg
66.39%
5Y Avg
68.84%
Market Cap
$10.30B
Gross Margin
94.63%
TTM Avg
99.67%
3Y Avg
99.84%
5Y Avg
99.89%
Market Cap
$10.83B
Gross Margin
75.55%
TTM Avg
78.40%
3Y Avg
77.70%
5Y Avg
76.19%
Market Cap
$10.21B
Gross Margin
13.07%
TTM Avg
12.36%
3Y Avg
12.43%
5Y Avg
12.55%
Market Cap
$10.21B
Gross Margin
66.48%
TTM Avg
69.16%
3Y Avg
69.73%
5Y Avg
70.75%
Market Cap
$10.19B
Gross Margin
70.03%
TTM Avg
68.45%
3Y Avg
69.94%
5Y Avg
74.18%
Market Cap
$10.96B
Gross Margin
63.64%
TTM Avg
63.66%
3Y Avg
64.40%
5Y Avg
64.61%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.55B | 51.97% | 52.23% | 46.15% | 43.85% |
| Universal Health Services, Inc. (UHS)vs › | $10.75B | 90.69% | 90.21% | 89.67% | 89.38% |
| Globus Medical, Inc. (GMED)vs › | $10.32B | 68.55% | 63.16% | 66.39% | 68.84% |
| ImmunityBio, Inc. (IBRX)vs › | $10.30B | 94.63% | 99.67% | 99.84% | 99.89% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.83B | 75.55% | 78.40% | 77.70% | 76.19% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 13.07% | 12.36% | 12.43% | 12.55% |
| Align Technology, Inc. (ALGN)vs › | $10.21B | 66.48% | 69.16% | 69.73% | 70.75% |
| 10x Genomics, Inc. (TXG)vs › | $10.19B | 70.03% | 68.45% | 69.94% | 74.18% |
| The Cooper Companies, Inc. (COO)vs › | $10.96B | 63.64% | 63.66% | 64.40% | 64.61% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 14.14% | 15.74% | 16.11% | 16.54% |
Gross Margin
52.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 52.76% |
| 2026-03-31 | 51.59% |
| 2025-12-31 | 52.05% |
| 2025-09-30 | 51.35% |
| 2025-06-30 | 53.40% |
| 2025-03-31 | 49.60% |
| 2024-12-31 | 48.29% |
| 2024-09-30 | 45.13% |
| 2024-06-30 | 43.30% |
| 2024-03-31 | 41.01% |
| 2023-12-31 | 40.51% |
| 2023-09-30 | 36.63% |
| 2023-06-30 | 34.35% |
| 2023-03-31 | 30.76% |
| 2022-12-31 | 45.72% |
| 2022-09-30 | 44.88% |
| 2022-06-30 | 44.80% |
| 2022-03-31 | 38.26% |
| 2021-12-31 | 35.61% |
| 2021-09-30 | 40.72% |
| 2021-06-30 | 40.22% |
| 2021-03-31 | 39.02% |
| 2020-12-31 | 35.51% |
| 2020-09-30 | 45.80% |
| 2020-06-30 | 22.33% |
| 2020-03-31 | 29.71% |
| 2019-12-31 | 19.65% |
| 2019-09-30 | 21.29% |
| 2019-06-30 | 16.22% |
| 2019-03-31 | 13.04% |
| 2018-12-31 | -3.18% |
| 2018-09-30 | -8.16% |
| 2018-06-30 | -14.71% |
| 2018-03-31 | -31.28% |
| 2017-12-31 | -73.85% |
| 2017-09-30 | -97.03% |
| 2017-06-30 | -95.84% |
